Cargando…

Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine

IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlecht, Nicolas F., Masika, Martin, Diaz, Angela, Nucci-Sack, Anne, Salandy, Anthony, Pickering, Sarah, Strickler, Howard D., Shankar, Viswanathan, Burk, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822084/ https://www.ncbi.nlm.nih.gov/pubmed/31651968 http://dx.doi.org/10.1001/jamanetworkopen.2019.14031

Ejemplares similares

Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine
por: Schlecht, Nicolas F., et al.
Publicado: (2021)

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history
por: Usyk, Mykhaylo, et al.
Publicado: (2022)

Cervical, Anal and Oral HPV in an Adolescent Inner-City Health Clinic Providing Free Vaccinations
por: Schlecht, Nicolas F., et al.
Publicado: (2012)

Distinct Ecological Niche of Anal, Oral, and Cervical Mucosal Microbiomes in Adolescent Women
por: Smith, Benjamin C., et al.
Publicado: (2016)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

TRiCit: A High-Throughput Approach to Detect Trichomonas vaginalis from ITS1 Amplicon Sequencing
por: Usyk, Mykhaylo, et al.
Publicado: (2023)

Impact of COVID-19 Mitigation Measures on Inner-City Female Youth in New York City
por: Diaz, Angela, et al.
Publicado: (2022)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2021)

The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women
por: Minkoff, Howard, et al.
Publicado: (2008)

Additive Hazard Regression Models: An Application to the Natural History of Human Papillomavirus
por: Xie, Xianhong, et al.
Publicado: (2013)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
por: Hernandez-Aguado, Juan J., et al.
Publicado: (2022)

A case of acute disseminated encephalomyelitis following human papillomavirus quadrivalent vaccination
por: Lee, Mina, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
por: Aponte-González, Johanna, et al.
Publicado: (2013)

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
por: Diaz, Maria Lina
Publicado: (2010)

Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
por: Murata, Shinya, et al.
Publicado: (2020)

Human papillomavirus infection among sexual partners attending a Sexually Transmitted Disease Clinic in Rio de Janeiro, Brazil
por: Afonso, L.A., et al.
Publicado: (2013)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
por: Brady, Allison M., et al.
Publicado: (2020)

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer
por: Schlecht, Nicolas F., et al.
Publicado: (2011)

Evaluation of the occurrence of sexual dysfunction and general quality of life in female patients with psoriasis
por: Kurizky, Patricia Shu, et al.
Publicado: (2018)

Female sexual distress in infertile Turkish women
por: Aydın, Serdar, et al.
Publicado: (2015)

Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure
por: Lai, Lilin, et al.
Publicado: (2020)

A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
por: Geier, David A., et al.
Publicado: (2014)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis
por: Hviid, Anders, et al.
Publicado: (2020)

A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men
por: Ellsworth, G.B., et al.
Publicado: (2018)

Prevention of Anal Condyloma with Quadrivalent Human Papillomavirus Vaccination of Older Men Who Have Sex with Men
por: Swedish, Kristin A., et al.
Publicado: (2014)

1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014)

Resolution of Harada disease-like uveitis after quadrivalent human papillomavirus vaccination: a case report
por: Kong, Kangjie, et al.
Publicado: (2021)

Regulation of the S-Locus Receptor Kinase and Self-Incompatibility in Arabidopsis thaliana
por: Strickler, Susan R., et al.
Publicado: (2013)

Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an ontario cohort of grade 8 girls
por: Smith, Leah M, et al.
Publicado: (2011)

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
por: Garland, Suzanne M., et al.
Publicado: (2016)

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
por: Cespedes, Michelle S., et al.
Publicado: (2018)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
por: Grein, Ingrid Herta Rotstein, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5advqr95847ua8ej043p17e19o